Amino-PEG4-Glu-Gly-Cit-PAB-MMAE is an intermediate composed of a cleavable Glu-Gly-Cit (EGCit) peptide to build an antibody drug conjugate (ADC). It can be conjugated with a monoclonal antibody (mAb) to target cancer cells, showcasing exceptional stability in the bloodstream, resisting degradation and neutrophil protease cleavage. Moreover, it facilitates intracellular payload release discreetly and without a trace.
Usually ships within 24 hours.